Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002073425 | SCV002386275 | likely benign | Hypertrophic cardiomyopathy | 2024-10-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002405282 | SCV002706147 | likely benign | Cardiovascular phenotype | 2021-05-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genetics, |
RCV001730379 | SCV001979024 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001730378 | SCV001980519 | likely benign | not provided | no assertion criteria provided | clinical testing |